Morgan Stanley Ensysce Biosciences, Inc. Call Options Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ENSC
# of Institutions
1Shares Held
100Call Options Held
0Put Options Held
0About Ensysce Biosciences, Inc.
- Ticker ENSC
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,918,900
- Market Cap $1.21M
- Description
- Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abu...